Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
oleh: Mohd H. Abdul-Aziz, Jeffrey Lipman, Jason A. Roberts
| Format: | Article |
|---|---|
| Diterbitkan: | BMC 2017-11-01 |
Deskripsi
Subjek
Augmented renal clearance; Critically ill; Meropenem; Pharmacokinetic; Pharmacodynamic; Risk assessment tool